RAPT Therapeutics, Inc. (RAPT) Shares Outstanding (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Shares Outstanding for 5 consecutive years, with $4.4 million as the latest value for Q3 2024.
- Quarterly Shares Outstanding fell 87.3% to $4.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Sep 2024, down 87.3% year-over-year, with the annual reading at $4.3 million for FY2023, 87.45% down from the prior year.
- Shares Outstanding hit $4.4 million in Q3 2024 for RAPT Therapeutics, roughly flat from $4.4 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $34.4 million in Q3 2023 to a low of $4.3 million in Q4 2023.
- Historically, Shares Outstanding has averaged $24.0 million across 5 years, with a median of $29.5 million in 2021.
- Biggest five-year swings in Shares Outstanding: grew 20.59% in 2021 and later plummeted 87.45% in 2023.
- Year by year, Shares Outstanding stood at $24.8 million in 2020, then increased by 19.3% to $29.6 million in 2021, then rose by 15.9% to $34.3 million in 2022, then plummeted by 87.45% to $4.3 million in 2023, then increased by 1.47% to $4.4 million in 2024.
- Business Quant data shows Shares Outstanding for RAPT at $4.4 million in Q3 2024, $4.4 million in Q2 2024, and $4.3 million in Q1 2024.